Szymczak, M.; Heidecke, H.; Żabińska, M.; Janek, Ł.; Wronowicz, J.; Kujawa, K.; Schulze-Forster, K.; Marek-Bukowiec, K.; Gołębiowski, T.; Banasik, M.
The Influence of Anti-PAR 1 and Anti-ACE 2 Antibody Levels on the Course of Specific Glomerulonephritis Types. J. Clin. Med. 2025, 14, 3178.
https://doi.org/10.3390/jcm14093178
AMA Style
Szymczak M, Heidecke H, Żabińska M, Janek Ł, Wronowicz J, Kujawa K, Schulze-Forster K, Marek-Bukowiec K, Gołębiowski T, Banasik M.
The Influence of Anti-PAR 1 and Anti-ACE 2 Antibody Levels on the Course of Specific Glomerulonephritis Types. Journal of Clinical Medicine. 2025; 14(9):3178.
https://doi.org/10.3390/jcm14093178
Chicago/Turabian Style
Szymczak, Maciej, Harald Heidecke, Marcelina Żabińska, Łucja Janek, Jakub Wronowicz, Krzysztof Kujawa, Kai Schulze-Forster, Karolina Marek-Bukowiec, Tomasz Gołębiowski, and Mirosław Banasik.
2025. "The Influence of Anti-PAR 1 and Anti-ACE 2 Antibody Levels on the Course of Specific Glomerulonephritis Types" Journal of Clinical Medicine 14, no. 9: 3178.
https://doi.org/10.3390/jcm14093178
APA Style
Szymczak, M., Heidecke, H., Żabińska, M., Janek, Ł., Wronowicz, J., Kujawa, K., Schulze-Forster, K., Marek-Bukowiec, K., Gołębiowski, T., & Banasik, M.
(2025). The Influence of Anti-PAR 1 and Anti-ACE 2 Antibody Levels on the Course of Specific Glomerulonephritis Types. Journal of Clinical Medicine, 14(9), 3178.
https://doi.org/10.3390/jcm14093178